A federal judge handed Abbott Laboratories another win this week in its yearslong battle over the safety of its formulas for ...

Abbott Laboratories Inc. convinced a federal judge that there wasn’t a feasible alternative design to a form of infant formula that parents said caused a fatal disease to their preterm child.

Abbott Laboratories’ third quarter results met Wall Street’s expectations for both revenue and non-GAAP profit, but the ...

"A small percentage of bottles (less than 1%) in the recalled lots have bottle caps that may hot have sealed completely," the company said in their announcement Friday Shafiq Najib is a former ...

What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon ...

Abbott Laboratories has initiated a voluntary recall of certain lots of ready-to-feed liquid products for infants and children, including the brands Similac and Pedialyte Electrolyte Solution, due to ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Medical devices made in Minnesota helped fuel second quarter sales gains for Abbott Laboratories, the Fortune 500 health care company that has a significant footprint in the state. Medical device ...

Abbott Laboratories (NYSE:ABT) develops, manufactures, and sells healthcare products, including pharmaceuticals, diagnostics, ...

According to a filing with the Securities and Exchange Commission dated October 14, 2025, CCLA Investment Management ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning.

The lawsuit claims these products, marketed as suitable for people with diabetes, contain harmful ingredients. The company also criticized the studies arguing they do not substantiate a link between ...